09:00 - 09:45

13 June

P2

Healing the mental health crisis: The emerging potential of psychedelics

With 1 in 4 people experiencing mental health issues worldwide, we ask this incredible panel of health and tech luminaries, can we solve the mental health crisis with psychedelics?

Catherine Bird

Clinical Trials Manager - Psychedelic Trials Group, King's College London

Christian Angermayer

Co-founder & Chairman - Apeiron Investment Group

Dr Ekaterina Malievskaia

Chief Innovations Office - COMPASS Pathways

Michael Stothard

Principal - firstminute capital

Festival Stage 1